Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors..
Pharmacogenomics J. 17(3), 237-241.
(2017). Absence of association of FCGR2A gene polymorphism rs1801274 with Kawasaki disease in Greek patients..
Cardiol Young. 25(4), 681-3.
(2015). Immunohistochemical study of immunological markers: HLAG, CD16, CD25, CD56 and CD68 in placenta tissues in recurrent pregnancy loss..
Histol Histopathol. 29(8), 1047-55.
(2014). Proinflammatory cytokine responses in patients with psoriasis..
Eur Cytokine Netw. 25(4), 63-8.
(2014). FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome..
Blood Coagul Fibrinolysis. 24(1), 35-9.
(2013). Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients..
Nephrology (Carlton). 14(5), 471-5.
(2009).